EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Epigenetics of Cardiovascular Disease: A New ‘Beat' in Coronary Artery Disease

Paul J Turgeon, Aravin N Sukumar, Philip A Marsden

Medical Epigenetics · 2014

DOI: 10.1159/000360766 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Epigenetics, 2014. Verfasst von Paul J Turgeon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada ; Keenan Research Centre for Biomedical Science and Li…. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome-wide association studies have become a powerful tool in the identification of disease-associated variants. Unfortunately, many of these studies have found that the estimated variability in cardiovascular disease (CVD) risk cannot be fully explained by traditional paradigms of genetic variation in protein-coding genes. Moreover, traditional views do not sufficiently explain the well-known link between CVD and environmental influence. We posit that epigenetics, defined as chromatin-based mechanisms important in the regulation of gene expression that do not involve changes in the DNA sequence per se, represents the missing link. The nuclear-based mechanisms that contribute to epigenetic gene regulation can be broadly separated into three unique but highly interrelated processes, namely DNA methylation and hydroxymethylation, histone density and post-translational modifications, and ribonucleic acid-based mechanisms. Together, they complement the cis/trans perspective on transcriptional control paradigms in blood vessels. Moreover, epigenetics provides a molecular basis for understanding how the environment influences the genome to modify CVD risk over the lifetime of a cell and its offspring. This review is an introduction to epigenetic function and CVD, with a focus on endothelial cell biology. Additionally, we highlight emerging concepts on epigenetic gene regulation that are highly relevant to atherosclerosis and coronary artery disease.

Schlagwörter

Stichwörter der Autor:innen

ANRILDNA methylationcardiovascular diseaseeNOSendothelial cellsepigeneticshistone posttranslational modifications and densitylong noncoding RNA

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada ; Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute, St. Michael's Hospital, Department of M…
  • Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada ; Keenan Research Centre for Biomedical Science and Li Ka Shing Knowledge Institute, St. Michael's Hospital, Department of Medicine, University o…
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada ; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada ; Keenan Research Centre for Biomedical Science…

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Turgeon, P. J., Sukumar, A. N., & Marsden, P. A. (2014). Epigenetics of Cardiovascular Disease: A New ‘Beat' in Coronary Artery Disease. Medical Epigenetics. https://doi.org/10.1159/000360766

Vancouver

Turgeon PJ, Sukumar AN, Marsden PA. Epigenetics of Cardiovascular Disease: A New ‘Beat' in Coronary Artery Disease. Medical Epigenetics. 2014. doi:10.1159/000360766

BibTeX
@article{Turgeon2014,
  author = {Turgeon, Paul J and Sukumar, Aravin N and Marsden, Philip A},
  title = {Epigenetics of Cardiovascular Disease: A New ‘Beat' in Coronary Artery Disease},
  journal = {Medical Epigenetics},
  year = {2014},
  doi = {10.1159/000360766}
}
Kostenlos starten →